NeurAxis, Inc. (NASDAQ:NRXS – Get Free Report) shares fell 2.8% during mid-day trading on Friday . The company traded as low as $2.80 and last traded at $2.80. 2,021 shares traded hands during trading, a decline of 78% from the average session volume of 9,040 shares. The stock had previously closed at $2.88.
NeurAxis Trading Down 2.8 %
The stock’s 50-day moving average is $3.05 and its 200-day moving average is $3.04. The stock has a market cap of $19.15 million, a price-to-earnings ratio of -0.95 and a beta of 4.30.
NeurAxis (NASDAQ:NRXS – Get Free Report) last posted its earnings results on Friday, August 9th. The company reported ($0.42) earnings per share for the quarter. The company had revenue of $0.61 million for the quarter.
NeurAxis Company Profile
NeurAxis, Inc, a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome.
Featured Articles
- Five stocks we like better than NeurAxis
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity
- What is the NASDAQ Stock Exchange?
- Autodesk Named a “Top Pick” by Morgan Stanley—Is It Time to Buy?
- What Investors Need to Know About Upcoming IPOs
- 4 Quirky ETFs With Big Potential for Impressive Gains
Receive News & Ratings for NeurAxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeurAxis and related companies with MarketBeat.com's FREE daily email newsletter.
